skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

Review

(1034) Views  (295) Full article downloads

Authors: Susana Hoette, Dermot S O’Callaghan, Carlos Jardim, et al

Published Date November 2010 Volume 2010:3 Pages 113 - 121
DOI: http://dx.doi.org/10.2147/JRLCR.S7115

Susana Hoette1,2, Dermot S O’Callaghan2, Carlos Jardim1, Rogerio Souza1
1Pulmonary Circulation Unit, Pulmonary Department, Heart Institute, University of São Paulo Medical School, Sao Paulo, Brazil; 2Hôpital Antoine Béclère, Université Paris Sud, Orsay, France

Abstract: Pulmonary hypertension is characterized by an increase in mean pulmonary arterial pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with an important role in the pathogenesis of pulmonary hypertension. In addition to its vasoconstrictive action, ET-1 also stimulates cell proliferation, fibrosis, and inflammation. The blockade of both receptors involved in the action of ET-1 is beneficial in the treatment of pulmonary hypertension. The use of endothelin dual receptor blockade leads to improvements in quality of life, functional capacity, and pulmonary hemodynamics in affected patients. This article reviews the importance of ET-1 in the pathogenesis of pulmonary hypertension and demonstrates the benefits of blockage of the action of ET-1 in this disease.

Keywords: pulmonary hypertension treatment, endothelin-1, endothelin receptor blockage, bosentan






Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Adenosine A2a receptor agonists as regulators of inflammation: pharmacology and therapeutic opportunities
The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases
Overview of the LDL receptor: relevance to cholesterol metabolism and future approaches for the treatment of coronary heart disease
Creatine supplementation upregulates excitation-contraction coupling in C2C12 myotubes
Effects of extracts from Cordyceps sinensis on M1 muscarinic acetylcholine receptor in vitro and in vivo
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy